Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sensorion
NCT05572073 · Sensorineural Hearing Loss, Bilateral
NCT04591093 · Sensorineural Hearing Loss, Bilateral
NCT05402813 · Sensorineural Hearing Loss, Bilateral, AUNB1, and more
NCT05230498 · Sensorineural Hearing Loss, Bilateral
NCT05154188 · Sensorineural Hearing Loss, Bilateral, Sensorineural Hearing Loss, Severe, and more
The University of South Florida Board of Trustees
Tampa, Florida
CHU Gui de Chauliac
Montpellier
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions